Journal of General Virology, Vol 78, 1295-1302, Copyright © 1997 by Society for General Microbiology

ARTICLES

Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis

P Fournier, NH Brons, GA Berbers, KH Wiesmuller, BT Fleckenstein, F Schneider, G Jung and CP Muller
Laboratoire National de Sante, Luxembourg, Luxembourg.

The haemagglutinin protein (H) of measles virus (MV) binds to susceptible cells and collaborates with the fusion protein (F) to mediate fusion of the virus with the cell membrane. Binding and fusion activity of the virus can be monitored by haemagglutination and haemolysis, respectively, of monkey erythrocytes. Most monoclonal antibodies (MAbs) with haemolysis inhibiting activity (HLI+) are either MV-F specific and do not inhibit haemagglutination (HI-), or they bind to MV-H and are HI+ by interfering with virus binding. We describe here a small panel of H-specific MAbs (BH47, BH59, BH103, BH129) which bind to a new linear neutralizing epitope, H244-250 (SELSQLS; NE domain), and which prevent virus-cell fusion (HLI+) but not virus binding (HI-). These antibodies also protect against MV encephalitis in an animal model. They do not compete with an HLI+/HI+ antibody (BH216) which binds to the haemagglutinin noose epitope (HNE). The antibodies described here and the HNE-specific antibodies are functionally distinct and define two topographically non-overlapping interfaces, supposedly with a bias towards the host cell MV-receptor and the fusion protein respectively. The proximity of the CD46 downregulating amino acid Arg-243 may suggest a functional link between the domain described here and the CD46 binding domain. This new protective linear site is also of potential interest for the design of a subunit-based vaccine.

This article has been cited by other articles:

				T. Finsterbusch, A. Wolbert, I. Deitemeier, K. Meyer, M. M. Mosquera, A. Mankertz, and S. Santibanez Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope J. Gen. Virol., November 1, 2009; 90(11): 2739 - 2745. [Abstract] [Full Text] [PDF]

				T. Hashiguchi, M. Kajikawa, N. Maita, M. Takeda, K. Kuroki, K. Sasaki, D. Kohda, Y. Yanagi, and K. Maenaka Crystal structure of measles virus hemagglutinin provides insight into effective vaccines PNAS, December 4, 2007; 104(49): 19535 - 19540. [Abstract] [Full Text] [PDF]

				E. A. Corey and R. M. Iorio Mutations in the Stalk of the Measles Virus Hemagglutinin Protein Decrease Fusion but Do Not Interfere with Virus-Specific Interaction with the Homologous Fusion Protein J. Virol., September 15, 2007; 81(18): 9900 - 9910. [Abstract] [Full Text] [PDF]

				S. Santibanez, S. Niewiesk, A. Heider, J. Schneider-Schaulies, G. A. M. Berbers, A. Zimmermann, A. Halenius, A. Wolbert, I. Deitemeier, A. Tischer, et al. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J. Gen. Virol., February 1, 2005; 86(2): 365 - 374. [Abstract] [Full Text] [PDF]

				S. Vincent, I. Tigaud, H. Schneider, C. J. Buchholz, Y. Yanagi, and D. Gerlier Restriction of Measles Virus RNA Synthesis by a Mouse Host Cell Line: trans-Complementation by Polymerase Components or a Human Cellular Factor(s) J. Virol., May 13, 2002; 76(12): 6121 - 6130. [Abstract] [Full Text] [PDF]

				M. Sugiyama, N. Ito, N. Minamoto, and S. Tanaka Identification of Immunodominant Neutralizing Epitopes on the Hemagglutinin Protein of Rinderpest Virus J. Virol., February 15, 2002; 76(4): 1691 - 1696. [Abstract] [Full Text] [PDF]

				S. Vincent, D. Gerlier, and S. N. Manié Measles Virus Assembly within Membrane Rafts J. Virol., November 1, 2000; 74(21): 9911 - 9915. [Abstract] [Full Text]

				K. C. El Kasmi, S. Fillon, D. M. Theisen, H. Hartter, N. H. C. Brons, and C. P. Muller Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies J. Gen. Virol., March 1, 2000; 81(3): 729 - 735. [Abstract] [Full Text]

				S. N. Manié, S. Debreyne, S. Vincent, and D. Gerlier Measles Virus Structural Components Are Enriched into Lipid Raft Microdomains: a Potential Cellular Location for Virus Assembly J. Virol., January 1, 2000; 74(1): 305 - 311. [Abstract] [Full Text]

				I. C. D. Johnston, V. ter Meulen, J. Schneider-Schaulies, and S. Schneider-Schaulies A Recombinant Measles Vaccine Virus Expressing Wild-Type Glycoproteins: Consequences for Viral Spread and Cell Tropism J. Virol., August 1, 1999; 73(8): 6903 - 6915. [Abstract] [Full Text]

				C. Escoffier, S. Manié, S. Vincent, C. P. Muller, M. Billeter, and D. Gerlier Nonstructural C Protein Is Required for Efficient Measles Virus Replication in Human Peripheral Blood Cells J. Virol., February 1, 1999; 73(2): 1695 - 1698. [Abstract] [Full Text]

				F. Bouche, W. Ammerlaan, F. Berthet, S. Houard, F. Schneider, and C. P. Muller Immunosorbent Assay Based on Recombinant Hemagglutinin Protein Produced in a High-Efficiency Mammalian Expression System for Surveillance of Measles Immunity J. Clin. Microbiol., March 1, 1998; 36(3): 721 - 726. [Abstract] [Full Text]